Search results

52 results

• Indications

  Indications Homepage Indications Indications The following pages provide in-depth information about chronic diseases of the intestines, oesophagus, and bile ducts. Crohn’s Disease Crohn’s disease is…
• Global presence

  Global presence Austria Dr. Falk Pharma Österreich GmbH Wolfgang-Pauli-Gasse 5 1140 Wien Phone: +43 1 577 35 16 0 Fax: +43 1 577 35 16 20 Email: office@drfalkpharma.at Web: https://www.drfalkpharma.at…
• NEWSROOM

  Renexxion Ireland Ltd. & Dr. Falk Pharma GmbH announce a Licensing and Collaboration Agreement

  Renexxion Ireland Ltd., a private biopharmaceutical company committed to delivering innovative drugs to patients with high unmet need gastrointestinal (“GI”) disorders, announced today that it has…
• NEWSROOM

  Dr. Falk Pharma and Zedira announce start of the phase 2b real-life study of ZED1227 for the treatment of Celiac Disease

  Dr. Falk Pharma GmbH and Zedira announce start of the phase 2b clinical trial of ZED1227, a direct-acting and specific inhibitor of tissue transglutaminase, in patients with Celiac Disease.
• NEWSROOM

  Adults with EOE market research survey

  Dr. Falk Pharma would like to thank all responders to our survey on Adults with EoE.
• NEWSROOM

  Merry Christmas

  ... and all the best for 2025!
• NEWSROOM

  Dr. Falk Pharma acquires Kynos Therapeutics

  ...adding acute pancreatitis as a therapeutic focus and further strengthening its development portfolio